NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

We all agree that the value of NWBO is very high, just based on what we know about the market for GBM, let along other cancers that this treatment has application.

Valuations are very tricky, just based on a host of assumptions and how the model assigns risk. That’s why partnering and licensing makes the most sense, which then lets the market reaction over time provide clarity on value, while taking some of the guess worth out of the equation.

But, at some point time value of money and general uncertainty takes a strong seat at the table, especially for a small undiversified biotech. And as valuations come more into focus, then it does make sense to sell and provide investors an opportunity to cash out at a premium.

I see this is as year long process until a buyout.